Skip to main content

Advertisement

SpringerLink
Log in

Optimization of the Cardiovascular Therapeutic Properties of Mesenchymal Stromal/Stem Cells–Taking the Next Step

  • Published:
Stem Cell Reviews and Reports Aims and scope Submit manuscript

Abstract

Despite current treatment options, cardiac failure is associated with significant morbidity and mortality highlighting a compelling clinical need for novel therapeutic approaches. Based on promising pre-clinical data, stem cell therapy has been suggested as a possible therapeutic strategy. Of the candidate cell types evaluated, mesenchymal stromal/stem cells (MSCs) have been widely evaluated due to their ease of isolation and ex vivo expansion, potential allogeneic utility and capacity to promote neo-angiogenesis and endogenous cardiac repair. However, the clinical application of MSCs for mainstream cardiovascular use is currently hindered by several important limitations, including suboptimal retention and engraftment and restricted capacity for bona fide cardiomyocyte regeneration. Consequently, this has prompted intense efforts to advance the therapeutic properties of MSCs for cardiovascular disease. In this review, we consider the scope of benefit from traditional plastic adherence-isolated MSCs and the lessons learned from their conventional use in preclinical and clinical studies. Focus is then given to the evolving strategies aimed at optimizing MSC therapy, including discussion of cell-targeted techniques that encompass the preparation, pre-conditioning and manipulation of these cells ex vivo, methods to improve their delivery to the heart and innovative substrate-directed strategies to support their interaction with the host myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ho, K., Anderson, K., Kannel, W., Grossman, W., & Levy, D. (1993). Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation, 88, 107–115.

    CAS  PubMed  Google Scholar 

  2. Fuchs, S., Baffour, R., Zhou, Y. F., et al. (2001). Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. Journal of the American College of Cardiology, 37, 1726–1732.

    CAS  PubMed  Google Scholar 

  3. Lunde, K., Solheim, S., Aakhus, S., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine, 355, 1199–1209.

    CAS  PubMed  Google Scholar 

  4. Orlic, D., Kajstura, J., Chimenti, S., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701–705.

    CAS  PubMed  Google Scholar 

  5. Losordo, D. W., Henry, T. D., Davidson, C., et al. (2011). Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circulation Research, 109, 428–436.

    CAS  PubMed  Google Scholar 

  6. Menasche, P., Hagege, A. A., Vilquin, J. T., et al. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. Journal of the American College of Cardiology, 41, 1078–1083.

    PubMed  Google Scholar 

  7. Psaltis, P. J., Zannettino, A. C. W., Worthley, S. G., & Gronthos, S. (2008). Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells, 26, 2201–2210.

    PubMed  Google Scholar 

  8. Psaltis, P. J., Harbuzariu, A., Delacroix, S., Holroyd, E. W., & Simari, R. D. (2011). Resident vascular progenitor cells–diverse origins, phenotype, and function. Journal of Cardiovascular Translational Research, 4, 161–176.

    PubMed  Google Scholar 

  9. Sabatini, F., Petecchia, L., Tavian, M., Jodon de Villeroche, V., Rossi, G. A., & Brouty-Boye, D. (2005). Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Laboratory Investigation, 85, 962–971.

    CAS  PubMed  Google Scholar 

  10. Zannettino, A. C. W., Paton, S., Arthur, A., et al. (2008). Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. Journal of Cellular Physiology, 214, 413–421.

    CAS  PubMed  Google Scholar 

  11. Shi, S., & Gronthos, S. (2003). Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. Journal of Bone and Mineral Research, 18, 696–704.

    PubMed  Google Scholar 

  12. Roufosse, C. A., Direkze, N. C., Otto, W. R., & Wright, N. A. (2004). Circulating mesenchymal stem cells. The International Journal of Biochemistry & Cell Biology, 36, 585–597.

    CAS  Google Scholar 

  13. Lee, O. K., Kuo, T. K., Chen, W. M., Lee, K. D., Hsieh, S. L., & Chen, T. H. (2004). Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood, 103, 1669–1675.

    CAS  PubMed  Google Scholar 

  14. In't Anker, P. S., Scherjon, S. A., Kleijburg-van der Keur, C., et al. (2004). Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22, 1338–1345.

    Google Scholar 

  15. Chen, S. L., Fang, W. W., Ye, F., et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American Journal of Cardiology, 94, 92–95.

    PubMed  Google Scholar 

  16. Amado, L. C., Saliaris, A. P., Schuleri, K. H., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 102, 11474–11479.

    CAS  PubMed  Google Scholar 

  17. Hare, J. M., Traverse, J. H., Henry, T. D., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54, 2277–2286.

    CAS  PubMed  Google Scholar 

  18. Quevedo, H. C., Hatzistergos, K. E., Oskouei, B. N., et al. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America, 106, 14022–14027.

    CAS  PubMed  Google Scholar 

  19. Psaltis, P. J., Carbone, A., Nelson, A. J., et al. (2010). Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy. JACC. Cardiovascular Interventions, 3, 974–983.

    PubMed  Google Scholar 

  20. Knight, R. L., Booth, C., Wilcox, H. E., Fisher, J., & Ingham, E. (2005). Tissue engineering of cardiac valves: Re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. The Journal of Heart Valve Disease, 14, 806–813.

    PubMed  Google Scholar 

  21. Yokokawa, M., Ohnishi, S., Ishibashi-Ueda, H., et al. (2008). Transplantation of mesenchymal stem cells improves atrioventricular conduction in a rat model of complete atrioventricular block. Cell Transplantation, 17, 1145–1155.

    PubMed  Google Scholar 

  22. Vulliet, P. R., Greeley, M., Halloran, S. M., MacDonald, K. A., & Kittleson, M. D. (2004). Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet, 363, 783–784.

    PubMed  Google Scholar 

  23. Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics, 3, 393–403.

    CAS  PubMed  Google Scholar 

  24. Psaltis, P. J., Paton, S., See, F., et al. (2010). Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. Journal of Cellular Physiology, 223, 530–540.

    CAS  PubMed  Google Scholar 

  25. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315–317.

    CAS  PubMed  Google Scholar 

  26. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93–98.

    PubMed  Google Scholar 

  27. Gnecchi, M., He, H., Melo, L. G., et al. (2009). Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells, 27, 971–979.

    CAS  PubMed  Google Scholar 

  28. Mills, W. R., Mal, N., Kiedrowski, M. J., et al. (2007). Stem cell therapy enhances electrical viability in myocardial infarction. Journal of Molecular and Cellular Cardiology, 42, 304–314.

    CAS  PubMed  Google Scholar 

  29. Ohnishi, S., Yanagawa, B., Tanaka, K., et al. (2007). Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. Journal of Molecular and Cellular Cardiology, 42, 88–97.

    CAS  PubMed  Google Scholar 

  30. Nagaya, N., Kangawa, K., Itoh, T., et al. (2005). Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 112, 1128–1135.

    PubMed  Google Scholar 

  31. Van Linthout, S., Savvatis, K., Miteva, K., et al. (2011). Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. European Heart Journal, 32(17), 2168–2178.

    PubMed  Google Scholar 

  32. Freyman, T., Polin, G., Osman, H., et al. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European Heart Journal, 27, 1114–1122.

    PubMed  Google Scholar 

  33. Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., et al. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circulation Research, 107, 913–922.

    CAS  PubMed  Google Scholar 

  34. Kraitchman, D. L., Heldman, A. W., Atalar, E., et al. (2003). In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation, 107, 2290–2293.

    PubMed  Google Scholar 

  35. Gyongyosi, M., Blanco, J., Marian, T., et al. (2008). Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circulation. Cardiovascular Imaging, 1, 94–103.

    PubMed  Google Scholar 

  36. Perin, E. C., Tian, M., Marini, F. C., 3rd, et al. (2011). Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One, 6, e22949.

    CAS  PubMed  Google Scholar 

  37. Psaltis, P. J., Simari, R. D., & Rodriguez-Porcel, M. (2012). Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: A clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging, 39, 165–181.

    PubMed  Google Scholar 

  38. Silva, G. V., Litovsky, S., Assad, J. A., et al. (2005). Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation, 111, 150–156.

    CAS  PubMed  Google Scholar 

  39. Schuleri, K. H., Amado, L. C., Boyle, A. J., et al. (2008). Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. American Journal of Physiology - Heart and Circulatory Physiology, 294, H2002–H2011.

    CAS  PubMed  Google Scholar 

  40. Arminan, A., Gandia, C., Bartual, M., et al. (2009). Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells and Development, 18, 907–918.

    CAS  PubMed  Google Scholar 

  41. Gao, L. R., Zhang, N. K., Bai, J., et al. (2010). The apelin-APJ pathway exists in cardiomyogenic cells derived from mesenchymal stem cells in vitro and in vivo. Cell Transplantation, 19, 949–958.

    PubMed  Google Scholar 

  42. Ge, D., Liu, X., Li, L., et al. (2009). Chemical and physical stimuli induce cardiomyocyte differentiation from stem cells. Biochemical and Biophysical Research Communications, 381, 317–321.

    CAS  PubMed  Google Scholar 

  43. Genovese, J. A., Spadaccio, C., Chachques, E., et al. (2009). Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Frontiers in Bioscience, 14, 2996–3002.

    CAS  PubMed  Google Scholar 

  44. Makino, S., Fukuda, K., Miyoshi, S., et al. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. The Journal of Clinical Investigation, 103, 697–705.

    CAS  PubMed  Google Scholar 

  45. Balana, B., Nicoletti, C., Zahanich, I., et al. (2006). 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Research, 16, 949–960.

    CAS  PubMed  Google Scholar 

  46. Feng, C., Zhu, J., Zhao, L., et al. (2009). Suberoylanilide hydroxamic acid promotes cardiomyocyte differentiation of rat mesenchymal stem cells. Experimental Cell Research, 315, 3044–3051.

    CAS  PubMed  Google Scholar 

  47. Yoon, J., Min, B. G., Kim, Y. H., Shim, W. J., Ro, Y. M., & Lim, D. S. (2005). Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiologica, 60, 277–284.

    PubMed  Google Scholar 

  48. Forte, G., Minieri, M., Cossa, P., et al. (2006). Hepatocyte growth factor effects on mesenchymal stem cells: Proliferation, migration, and differentiation. Stem Cells, 24, 23–33.

    CAS  PubMed  Google Scholar 

  49. Li, H., Yu, B., Zhang, Y., Pan, Z., & Xu, W. (2006). Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochemical and Biophysical Research Communications, 341, 320–325.

    CAS  PubMed  Google Scholar 

  50. Herrmann, J. L., Abarbanell, A. M., Weil, B. R., et al. (2010). Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 299, R371–R378.

    CAS  PubMed  Google Scholar 

  51. Koninckx, R., Hensen, K., Daniels, A., et al. (2009). Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy, 11, 778–792.

    CAS  PubMed  Google Scholar 

  52. He, X. Q., Chen, M. S., Li, S. H., et al. (2010). Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner. Molecular and Cellular Biochemistry, 339, 89–98.

    CAS  PubMed  Google Scholar 

  53. Labovsky, V., Hofer, E. L., Feldman, L., et al. (2010). Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes. Differentiation, 79, 93–101.

    CAS  PubMed  Google Scholar 

  54. Nygren, J. M., Jovinge, S., Breitbach, M., et al. (2004). Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Medicine, 10, 494–501.

    CAS  PubMed  Google Scholar 

  55. Martens, T. P., See, F., Schuster, M. D., et al. (2006). Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nature Clinical Practice. Cardiovascular Medicine, 3(Suppl 1), S18–S22.

    CAS  PubMed  Google Scholar 

  56. Shake, J. G., Gruber, P. J., Baumgartner, W. A., et al. (2002). Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. The Annals of Thoracic Surgery, 73, 1919–1925.

    PubMed  Google Scholar 

  57. Tsuji, H., Miyoshi, S., Ikegami, Y., et al. (2010). Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circulation Research, 106, 1613–1623.

    CAS  PubMed  Google Scholar 

  58. Jumabay, M., Zhang, R., Yao, Y., Goldhaber, J. I., & Bostrom, K. I. (2010). Spontaneously beating cardiomyocytes derived from white mature adipocytes. Cardiovascular Research, 85, 17–27.

    CAS  PubMed  Google Scholar 

  59. Gnecchi, M., Zhang, Z., Ni, A., & Dzau, V. J. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research, 103, 1204–1219.

    CAS  PubMed  Google Scholar 

  60. Godier-Furnemont, A. F., Martens, T. P., Koeckert, M. S., et al. (2011). Composite scaffold provides a cell delivery platform for cardiovascular repair. Proceedings of the National Academy of Sciences of the United States of America, 108, 7974–7979.

    CAS  PubMed  Google Scholar 

  61. Thangarajah, H., Vial, I. N., Chang, E., et al. (2009). IFATS collection: Adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells, 27, 266–274.

    CAS  PubMed  Google Scholar 

  62. See, F., Seki, T., Psaltis, P. J., et al. (2010) Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia. Journal of Cellular and Molecular Medicine.

  63. Mangi, A. A., Noiseux, N., Kong, D., et al. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine, 9, 1195–1201.

    CAS  PubMed  Google Scholar 

  64. Kinnaird, T., Stabile, E., Burnett, M. S., et al. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circulation Research, 94, 678–685.

    CAS  PubMed  Google Scholar 

  65. Xu, M., Uemura, R., Dai, Y., Wang, Y., Pasha, Z., & Ashraf, M. (2007). In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. Journal of Molecular and Cellular Cardiology, 42, 441–448.

    CAS  PubMed  Google Scholar 

  66. Rogers, T. B., Pati, S., Gaa, S., et al. (2011). Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes. Journal of Molecular and Cellular Cardiology, 50, 346–356.

    CAS  PubMed  Google Scholar 

  67. Benzhi, C., Limei, Z., Ning, W., et al. (2009). Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes. Journal of Molecular and Cellular Cardiology, 47, 41–48.

    PubMed  Google Scholar 

  68. Lai, R. C., Arslan, F., Lee, M. M., et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Research, 4, 214–222.

    CAS  PubMed  Google Scholar 

  69. Du, Y. Y., Zhou, S. H., Zhou, T., et al. (2008). Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy, 10, 469–478.

    CAS  PubMed  Google Scholar 

  70. Lee, R. H., Pulin, A. A., Seo, M. J., et al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell, 5, 54–63.

    CAS  PubMed  Google Scholar 

  71. Ishikane, S., Yamahara, K., Sada, M., et al. (2010). Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. Journal of Molecular and Cellular Cardiology, 49, 753–761.

    CAS  PubMed  Google Scholar 

  72. Li, L., Zhang, S., Zhang, Y., Yu, B., Xu, Y., & Guan, Z. (2009). Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Molecular Biology Reports, 36, 725–731.

    CAS  PubMed  Google Scholar 

  73. Dixon, J. A., Gorman, R. C., Stroud, R. E., et al. (2009). Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation, 120, S220–S229.

    CAS  PubMed  Google Scholar 

  74. Schneider, C., Jaquet, K., Geidel, S., et al. (2009). Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: Strain rate imaging in a model of hibernating myocardium. Journal of the American Society of Echocardiography, 22, 1180–1189.

    PubMed  Google Scholar 

  75. Javazon, E. H., Colter, D. C., Schwarz, E. J., & Prockop, D. J. (2001). Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells, 19, 219–225.

    CAS  PubMed  Google Scholar 

  76. Miura, M., Miura, Y., Padilla-Nash, H. M., et al. (2006). Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells, 24, 1095–1103.

    PubMed  Google Scholar 

  77. Jeong, J. O., Han, J. W., Kim, J. M., et al. (2011). Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circulation Research, 108, 1340–1347.

    CAS  PubMed  Google Scholar 

  78. Schachinger, V., Erbs, S., Elsasser, A., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355, 1210–1221.

    CAS  PubMed  Google Scholar 

  79. Wollert, K. C., Meyer, G. P., Lotz, J., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet, 364, 141–148.

    PubMed  Google Scholar 

  80. Lipinski, M. J., Biondi-Zoccai, G. G., Abbate, A., et al. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. Journal of the American College of Cardiology, 50, 1761–1767.

    PubMed  Google Scholar 

  81. Pfeffer, M. A., Greaves, S. C., Arnold, J. M. O., et al. (1997). Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction: The healing and early afterload reducing therapy trial. Circulation, 95, 2643–2651.

    CAS  PubMed  Google Scholar 

  82. Katritsis, D. G., Sotiropoulou, P. A., Karvouni, E., et al. (2005). Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheterization and Cardiovascular Interventions, 65, 321–329.

    PubMed  Google Scholar 

  83. Yang, Z., Zhang, F., Ma, W., et al. (2010). A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: Delivery via a noninfarct-relative artery. Cardiovascular Therapeutics, 28, 380–385.

    PubMed  Google Scholar 

  84. Chen, S., Liu, Z., Tian, N., et al. (2006). Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. The Journal of Invasive Cardiology, 18, 552–556.

    PubMed  Google Scholar 

  85. Katritsis, D. G., Sotiropoulou, P., Giazitzoglou, E., Karvouni, E., & Papamichail, M. (2007). Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace, 9, 167–171.

    PubMed  Google Scholar 

  86. Williams, A. R., Trachtenberg, B., Velazquez, D. L., et al. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: Functional recovery and reverse remodeling. Circulation Research, 108, 792–796.

    CAS  PubMed  Google Scholar 

  87. Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838–3843.

    PubMed  Google Scholar 

  88. Fischer, U. M., Harting, M. T., Jimenez, F., et al. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells and Development, 18, 683–692.

    CAS  PubMed  Google Scholar 

  89. Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B., Lurvink, E. G., Willemze, R., & Fibbe, W. E. (2006). Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood, 108, 2114–2120.

    CAS  PubMed  Google Scholar 

  90. Poncelet, A. J., Vercruysse, J., Saliez, A., & Gianello, P. (2007). Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation, 83, 783–790.

    PubMed  Google Scholar 

  91. Robey, T. E., Saiget, M. K., Reinecke, H., & Murry, C. E. (2008). Systems approaches to preventing transplanted cell death in cardiac repair. Journal of Molecular and Cellular Cardiology, 45, 567–581.

    CAS  PubMed  Google Scholar 

  92. Reinecke, H., Zhang, M., Bartosek, T., & Murry, C. E. (1999). Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation, 100, 193–202.

    CAS  PubMed  Google Scholar 

  93. Simmons, P. J., & Torok-Storb, B. (1991). Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 78, 55–62.

    CAS  PubMed  Google Scholar 

  94. Gronthos, S., Simmons, P. J., Graves, S. E., & Robey, P. G. (2001). Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone, 28, 174–181.

    CAS  PubMed  Google Scholar 

  95. Simmons, P. J., Masinovsky, B., Longenecker, B. M., Berenson, R., Torok-Storb, B., & Gallatin, W. M. (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood, 80, 388–395.

    CAS  PubMed  Google Scholar 

  96. Sacchetti, B., Funari, A., Michienzi, S., et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell, 131, 324–336.

    CAS  PubMed  Google Scholar 

  97. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C., & Deliliers, G. L. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Experimental Hematology, 30, 783–791.

    CAS  PubMed  Google Scholar 

  98. Gronthos, S., & Simmons, P. J. (1995). The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood, 85, 929–940.

    CAS  PubMed  Google Scholar 

  99. Schwab, K. E., & Gargett, C. E. (2007). Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Human Reproduction, 22, 2903–2911.

    CAS  PubMed  Google Scholar 

  100. Gronthos, S., Fitter, S., Diamond, P., Simmons, P. J., Itescu, S., & Zannettino, A. C. (2007). A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells and Development, 16, 953–963.

    CAS  PubMed  Google Scholar 

  101. Gronthos, S., McCarty, R., Mrozik, K., et al. (2009). Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: Generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues. Stem Cells and Development, 18, 1253–1262.

    CAS  PubMed  Google Scholar 

  102. Hamamoto, H., Gorman, J. H., 3rd, Ryan, L. P., et al. (2009). Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: The effect of cell dosage. The Annals of Thoracic Surgery, 87, 794–801.

    PubMed  Google Scholar 

  103. Tondreau, T., Lagneaux, L., Dejeneffe, M., et al. (2004). Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: Phenotype, proliferation kinetics and differentiation potential. Cytotherapy, 6, 372–379.

    CAS  PubMed  Google Scholar 

  104. Lushaj, E. B., Anstadt, E., Haworth, R., et al. (2011). Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. Cytotherapy, 13, 400–406.

    CAS  PubMed  Google Scholar 

  105. Jiang, Y., Jahagirdar, B., Reinhardt, R., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418, 41–49.

    CAS  PubMed  Google Scholar 

  106. Pelacho, B., Nakamura, Y., Zhang, J., et al. (2007). Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. Journal of Tissue Engineering and Regenerative Medicine, 1, 51–59.

    CAS  PubMed  Google Scholar 

  107. Spees, J. L., Gregory, C. A., Singh, H., et al. (2004). Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Molecular Therapy, 9, 747–756.

    CAS  PubMed  Google Scholar 

  108. Crespo-Diaz, R., Behfar, A., Butler, G. W., et al. (2011). Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplantation, 20, 797–811.

    PubMed  Google Scholar 

  109. Hoogduijn, M. J., Crop, M. J., Peeters, A. M., et al. (2009). Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart. American Journal of Transplantation, 9, 222–230.

    CAS  PubMed  Google Scholar 

  110. Bai, X., Yan, Y., Song, Y. H., et al. (2010). Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. European Heart Journal, 31, 489–501.

    CAS  PubMed  Google Scholar 

  111. Bayes-Genis, A., Soler-Botija, C., Farre, J., et al. (2010). Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. Journal of Molecular and Cellular Cardiology, 49, 771–780.

    CAS  PubMed  Google Scholar 

  112. Troyer, D. L., & Weiss, M. L. (2008). Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells, 26, 591–599.

    PubMed  Google Scholar 

  113. Iop, L., Chiavegato, A., Callegari, A., et al. (2008). Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. Cell Transplantation, 17, 679–694.

    PubMed  Google Scholar 

  114. Kadivar, M., Khatami, S., Mortazavi, Y., Shokrgozar, M. A., Taghikhani, M., & Soleimani, M. (2006). In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochemical and Biophysical Research Communications, 340, 639–647.

    CAS  PubMed  Google Scholar 

  115. Gaebel, R., Furlani, D., Sorg, H., et al. (2011). Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One, 6(2), e15652.

    CAS  PubMed  Google Scholar 

  116. Bieback, K., Kern, S., Kluter, H., & Eichler, H. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells, 22, 625–634.

    PubMed  Google Scholar 

  117. Schmidt, D., Mol, A., Breymann, C., et al. (2006). Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation, 114, I125–I131.

    PubMed  Google Scholar 

  118. Lee, S. T., White, A. J., Matsushita, S., et al. (2011). Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. Journal of the American College of Cardiology, 57, 455–465.

    PubMed  Google Scholar 

  119. Gambini, E., Pompilio, G., Biondi, A., et al. (2011). C-kit+cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. Cardiovascular Research, 89, 362–373.

    CAS  PubMed  Google Scholar 

  120. Sethe, S., Scutt, A., & Stolzing, A. (2006). Aging of mesenchymal stem cells. Ageing Research Reviews, 5, 91–116.

    CAS  PubMed  Google Scholar 

  121. Tokalov, S. V., Gruner, S., Schindler, S., Wolf, G., Baumann, M., & Abolmaali, N. (2007). Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells and Development, 16, 439–446.

    CAS  PubMed  Google Scholar 

  122. Hacia, J. G., Lee, C. C., Jimenez, D. F., et al. (2008). Age-related gene expression profiles of rhesus monkey bone marrow-derived mesenchymal stem cells. Journal of Cellular Biochemistry, 103, 1198–1210.

    CAS  PubMed  Google Scholar 

  123. Zhang, H., Fazel, S., Tian, H., et al. (2005). Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. American Journal of Physiology - Heart and Circulatory Physiology, 289, H2089–H2096.

    CAS  PubMed  Google Scholar 

  124. Khan, M., Mohsin, S., Khan, S. N., & Riazuddin, S. (2011). Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. Journal of Cellular and Molecular Medicine, 15, 1515–1527.

    CAS  PubMed  Google Scholar 

  125. Khan, M., Kwiatkowski, P., Rivera, B. K., & Kuppusamy, P. (2010). Oxygen and oxygenation in stem-cell therapy for myocardial infarction. Life Sciences, 87, 269–274.

    CAS  PubMed  Google Scholar 

  126. Kofoed, H., Sjontoft, E., Siemssen, S. O., & Olesen, H. P. (1985). Bone marrow circulation after osteotomy. Blood flow, pO2, pCO2, and pressure studied in dogs. Acta Orthopaedica Scandinavica, 56, 400–403.

    CAS  PubMed  Google Scholar 

  127. Hu, X., Yu, S. P., Fraser, J. L., et al. (2008). Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. The Journal of Thoracic and Cardiovascular Surgery, 135, 799–808.

    CAS  PubMed  Google Scholar 

  128. Li, J. H., Zhang, N., & Wang, J. A. (2008). Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. Journal of Endocrinological Investigation, 31, 103–110.

    CAS  PubMed  Google Scholar 

  129. Rebelatto, C. K., Aguiar, A. M., Senegaglia, A. C., et al. (2009). Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents. Biochemical and Biophysical Research Communications, 378, 456–461.

    CAS  PubMed  Google Scholar 

  130. Afzal, M. R., Haider, H., Idris, N. M., Jiang, S., Ahmed, R. P., & Ashraf, M. (2010). Pre-conditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling. Antioxidants & Redox Signaling, 12, 693–702.

    CAS  Google Scholar 

  131. Suzuki, Y., Kim, H. W., Ashraf, M., & Haider, H. (2010). Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. American Journal of Physiology - Heart and Circulatory Physiology, 299, H1077–H1082.

    CAS  PubMed  Google Scholar 

  132. Suzuki, K., Smolenski, R. T., Jayakumar, J., Murtuza, B., Brand, N. J., & Yacoub, M. H. (2000). Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation, 102(19 Suppl 3), III216–III221.

    CAS  PubMed  Google Scholar 

  133. Wang, X., Zhao, T., Huang, W., et al. (2009). Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells, 27, 3021–3031.

    CAS  PubMed  Google Scholar 

  134. Chang, W., Song, B.-W., Lim, S., et al. (2009). Mesenchymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem Cells, 27, 2283–2292.

    CAS  PubMed  Google Scholar 

  135. Yang, Y. J., Qian, H. Y., Huang, J., et al. (2009). Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 2076–2082.

    PubMed  Google Scholar 

  136. Yang, Y., Mou, Y., Hu, S. J., & Fu, M. (2009). Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins. European Journal of Heart Failure, 11, 6–13.

    CAS  PubMed  Google Scholar 

  137. Lin, Y. C., Leu, S., Sun, C. K., et al. (2010). Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. Journal of Translational Medicine, 8, 88.

    PubMed  Google Scholar 

  138. Haider, H., Lee, Y. J., Jiang, S., Ahmed, R. P., Ryon, M., & Ashraf, M. (2010). Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells. American Journal of Physiology - Heart and Circulatory Physiology, 299, H1395–H1404.

    CAS  PubMed  Google Scholar 

  139. Numasawa, Y., Kimura, T., Miyoshi, S., et al. (2011). Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis. Stem Cells, 29, 1405–1414.

    CAS  PubMed  Google Scholar 

  140. Wang, Y., Zhang, D., Ashraf, M., et al. (2010). Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. American Journal of Physiology - Heart and Circulatory Physiology, 298, H275–H286.

    CAS  PubMed  Google Scholar 

  141. Kinnaird, T., Stabile, E., Burnett, M. S., et al. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 109, 1543–1549.

    CAS  PubMed  Google Scholar 

  142. Herrmann, J. L., Wang, Y., Abarbanell, A. M., Weil, B. R., Tan, J., & Meldrum, D. R. (2010). Pre-conditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock, 33, 24–30.

    CAS  PubMed  Google Scholar 

  143. Pasha, Z., Wang, Y., Sheikh, R., Zhang, D., Zhao, T., & Ashraf, M. (2008). Pre-conditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovascular Research, 77, 134–142.

    CAS  PubMed  Google Scholar 

  144. Yao, Y., Zhang, F., Wang, L., et al. (2009). Lipopolysaccharide pre-conditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. Journal of Biomedical Science, 16, 74.

    PubMed  Google Scholar 

  145. Matsumoto, R., Omura, T., Yoshiyama, M., et al. (2005). Vascular endothelial growth factor–expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1168–1173.

    CAS  PubMed  Google Scholar 

  146. Guo, J., Lin, G., Bao, C., Hu, Z., Chu, H., & Hu, M. (2008). Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction. Journal of Biomedical Science, 15, 89–97.

    CAS  PubMed  Google Scholar 

  147. Abbott, J. D., Huang, Y., Liu, D., Hickey, R., Krause, D. S., & Giordano, F. J. (2004). Stromal cell–derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation, 110, 3300–3305.

    PubMed  Google Scholar 

  148. Kijowski, J., Baj-Krzyworzeka, M., Majka, M., et al. (2001). The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells, 19, 453–466.

    CAS  PubMed  Google Scholar 

  149. Zhuang, Y., Chen, X., Xu, M., Zhang, L. Y., & Xiang, F. (2009). Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction. Chinese Medical Journal, 122, 183–187.

    PubMed  Google Scholar 

  150. Tang, J., Wang, J., Guo, L., et al. (2010). Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Molecules and Cells, 29, 9–19.

    PubMed  Google Scholar 

  151. Guo, Y. H., He, J. G., Wu, J. L., et al. (2008). Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. Cytotherapy, 10, 857–867.

    PubMed  Google Scholar 

  152. Huang, J., Zhang, Z., Guo, J., et al. (2010). Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circulation Research, 106, 1753–1762.

    CAS  PubMed  Google Scholar 

  153. Tang, J., Wang, J., Zheng, F., et al. (2010). Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Molecular and Cellular Biochemistry, 339, 107–118.

    CAS  PubMed  Google Scholar 

  154. Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997). PI3K: Downstream AKTion blocks apoptosis. Cell, 88, 435–437.

    CAS  PubMed  Google Scholar 

  155. Datta, S. R., Brunet, A., & Greenberg, M. E. (1999). Cellular survival: A play in three Akts. Genes & Development, 13, 2905–2927.

    CAS  Google Scholar 

  156. Somanath, P. R., Razorenova, O. V., Chen, J., & Byzova, T. V. (2006). Akt1 in endothelial cell and angiogenesis. Cell Cycle, 5, 512–518.

    CAS  PubMed  Google Scholar 

  157. Gnecchi, M., He, H., Liang, O. D., et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature Medicine, 11, 367–368.

    CAS  PubMed  Google Scholar 

  158. Gnecchi, M., He, H., Noiseux, N., et al. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. The FASEB Journal, 20, 661–669.

    CAS  Google Scholar 

  159. Mirotsou, M., Zhang, Z., Deb, A., et al. (2007). Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proceedings of the National Academy of Sciences of the United States of America, 104, 1643–1648.

    CAS  PubMed  Google Scholar 

  160. Song, S. W., Chang, W., Song, B. W., et al. (2009). Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells, 27, 1358–1365.

    CAS  PubMed  Google Scholar 

  161. Jiang, Y., Chen, L., Tang, Y., et al. (2010). HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: An MRI study. Basic Research in Cardiology, 105, 431–442.

    CAS  PubMed  Google Scholar 

  162. Taljaard, M., Ward, M. R., Kutryk, M. J., et al. (2010). Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. American Heart Journal, 159, 354–360.

    CAS  PubMed  Google Scholar 

  163. Mias, C., Trouche, E., Seguelas, M. H., et al. (2008). Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells, 26, 1749–1757.

    CAS  PubMed  Google Scholar 

  164. Behfar, A., Zingman, L. V., Hodgson, D. M., et al. (2002). Stem cell differentiation requires a paracrine pathway in the heart. The FASEB Journal, 16, 1558–1566.

    Google Scholar 

  165. Behfar, A., Perez-Terzic, C., Faustino, R. S., et al. (2007). Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. The Journal of Experimental Medicine, 204, 405–420.

    CAS  PubMed  Google Scholar 

  166. Behfar, A., Yamada, S., Crespo-Diaz, R., et al. (2010). Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. Journal of the American College of Cardiology, 56, 721–734.

    CAS  PubMed  Google Scholar 

  167. Bartunek, J., Wijns, W., Dolatabadi, D., et al. (2011). C-cure multicenter trial: Lineage specific bone marrow derived cardiopoietic mesenchymal stem cells for the treatment of ischaemic cardiomyopathy. Journal of the American College of Cardiology, 57, E200. Abstract.

    Google Scholar 

  168. Yang, Y.-J., Qian, H.-Y., Huang, J., et al. (2008). Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. European Heart Journal, 29, 1578–1590.

    PubMed  Google Scholar 

  169. Xu, R., Chen, J., Cong, X., Hu, S., & Chen, X. (2008). Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. Journal of Cellular Biochemistry, 103, 256–269.

    CAS  PubMed  Google Scholar 

  170. Khan, M., Meduru, S., Mohan, I. K., et al. (2009). Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. Journal of Molecular and Cellular Cardiology, 47, 275–287.

    CAS  PubMed  Google Scholar 

  171. Zhang, H., Hou, J. F., Shen, Y., Wang, W., Wei, Y. J., & Hu, S. (2010). Low level laser irradiation precondition to create friendly milieu of infarcted myocardium and enhance early survival of transplanted bone marrow cells. Journal of Cellular and Molecular Medicine, 14, 1975–1987.

    CAS  PubMed  Google Scholar 

  172. Briones, E., Lacalle, J. R., Marin, I. (2009) Transmyocardial laser revascularization versus medical therapy for refractory angina. Cochrane Database of Systematic Reviews CD003712.

  173. Psaltis, P. J., & Worthley, S. G. (2009). Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System. Journal of Cardiovascular Translational Research, 2, 48–62.

    PubMed  Google Scholar 

  174. Reyes, G., Allen, K. B., Alvarez, P., et al. (2010). Midterm results after bone marrow laser revascularization for treating refractory angina. BMC Cardiovascular Disorders, 10, 42.

    PubMed  Google Scholar 

  175. Traverse, J. H., Henry, T. D., Ellis, S. G., et al. (2011). Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial. Journal of the American Medical Association, 306, 2110–2119.

    CAS  PubMed  Google Scholar 

  176. Ly, H. Q., Hoshino, K., Pomerantseva, I., et al. (2009). In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction. European Heart Journal, 30, 2861–2868.

    PubMed  Google Scholar 

  177. Hou, D., Youssef, E. A., Brinton, T. J., et al. (2005). Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation, 112, I150–I156.

    PubMed  Google Scholar 

  178. Perin, E. C., Silva, G. V., Assad, J. A., et al. (2008). Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 44, 486–495.

    CAS  PubMed  Google Scholar 

  179. Mitchell, A. J., Sabondjian, E., Sykes, J., et al. (2010). Comparison of initial cell retention and clearance kinetics after subendocardial or subepicardial injections of endothelial progenitor cells in a canine myocardial infarction model. Journal of Nuclear Medicine, 51, 413–417.

    PubMed  Google Scholar 

  180. Psaltis, P., Zannettino, A., Gronthos, S., & Worthley, S. (2010). Intramyocardial navigation and mapping for stem cell delivery. Journal of Cardiovascular Translational Research, 3, 135–146.

    PubMed  Google Scholar 

  181. Christman, K. L., Vardanian, A. J., Fang, Q., Sievers, R. E., Fok, H. H., & Lee, R. J. (2004). Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. Journal of the American College of Cardiology, 44, 654–660.

    CAS  PubMed  Google Scholar 

  182. Leor, J., Amsalem, Y., & Cohen, S. (2005). Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacology and Therapeutics, 105, 151–163.

    CAS  PubMed  Google Scholar 

  183. Kofidis, T., Lebl, D. R., Martinez, E. C., Hoyt, G., Tanaka, M., & Robbins, R. C. (2005). Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation, 112(9 Suppl), I173–I177.

    PubMed  Google Scholar 

  184. Terrovitis, J., Lautamaki, R., Bonios, M., et al. (2009). Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. Journal of the American College of Cardiology, 54, 1619–1626.

    PubMed  Google Scholar 

  185. Davis, M. E., Motion, J. P. M., Narmoneva, D. A., et al. (2005). Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation, 111, 442–450.

    CAS  PubMed  Google Scholar 

  186. Segers, V. F., Tokunou, T., Higgins, L. J., MacGillivray, C., Gannon, J., & Lee, R. T. (2007). Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation, 116, 1683–1692.

    CAS  PubMed  Google Scholar 

  187. Barnett, B. P., Ruiz-Cabello, J., Hota, P., et al. (2011). Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology, 258, 182–191.

    PubMed  Google Scholar 

  188. Melero-Martin, J. M., De Obaldia, M. E., Kang, S. Y., et al. (2008). Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circulation Research, 103, 194–202.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Dr Richardson is supported by an International Postgraduate Research Scholarship, University of Adelaide and an Australian Postgraduate Award. Dr Psaltis has received funding from the National Health and Medical Research Council of Australia and the Royal Australasian College of Physicians.

Conflicts of interest

The authors report no conflicts of interest.

Author information

Authors and Affiliations

  1. Cardiovascular Research Centre, Royal Adelaide Hospital and Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia

    James D. Richardson, Adam J. Nelson, Stephen G. Worthley & Peter J. Psaltis

  2. Department of Haematology, SA Pathology and Centre for Stem Cell Research, Robinson Institute, Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia

    Andrew C. W. Zannettino & Stan Gronthos

  3. Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN, USA

    Peter J. Psaltis

Authors
  1. James D. Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam J. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew C. W. Zannettino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stan Gronthos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephen G. Worthley
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter J. Psaltis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter J. Psaltis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richardson, J.D., Nelson, A.J., Zannettino, A.C.W. et al. Optimization of the Cardiovascular Therapeutic Properties of Mesenchymal Stromal/Stem Cells–Taking the Next Step. Stem Cell Rev and Rep 9, 281–302 (2013). https://doi.org/10.1007/s12015-012-9366-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12015-012-9366-7

Keywords

Search

Navigation